Recent

% | $
Quotes you view appear here for quick access.

Amarin Corporation plc Message Board

  • williams4076 williams4076 Apr 4, 2013 4:15 PM Flag

    AZN & AMRN M&A report done on March 30, 2013

    Merger and Acquisition Scenario
    Astrazeneca PLC (AZN) and Amarin Corporation PLC (AMRN)
    Date: Mar 30, 2013
    Format: HTML
    Price: $100.00

    View Report Sample »

    Abstract
    Revere Data's Merger & Acquisition Scenario Report offers independent, objective and insightful analysis into a hypothetical combination of Astrazeneca PLC (AZN) with Amarin Corporation PLC (AMRN) . The Revere report begins by identifying Astrazeneca PLC products that are either complementary or overlapping to Amarin Corporation PLC products. Astrazeneca PLC suppliers are then displayed alongside Amarin Corporation PLC suppliers, with overlapping suppliers to both firms highlighted. Dependent suppliers to both companies are also displayed, including the percentage of dependent revenue if known. Top Astrazeneca PLC customers and top Amarin Corporation PLC customers, including overlapping customers, are also shown. The Revere report then includes key business relationship data in the area of strategic partnerships for each company. Additional content and features include Lines of Business Summaries, Product Summaries, Individual Astrazeneca PLC Product Line and Amarin Corporation PLC Product Line Details, Astrazeneca PLC Earnings and Amarin Corporation PLC Earnings Summaries, and pro forma financial statements. Revere Data Merger & Acquisition Scenario Reports are an essential source of competitive insight into an array of potential merger, acquisition, takeover, consolidation, rollup or other combination scenarios, with particular focus in the healthcare, biotechnology, information technology, finance and media sectors. Revere's extensive databases on key business relationships, product lines, focused sectors, and financial performance indicators provide a rich and integrated information source for investment banking, corporate finance, C-level executives, management consultants, marketing, and business intelligence professionals who want actionable answers and ideas in seconds.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
AMRN
2.52+0.07(+2.86%)Jul 2 4:00 PMEDT